Monocyte Transcriptional Profiling Highlights a Shift in Immune Signatures Over the Course of Illness in Schizophrenia

Abstract

With advanced understanding of the intricate interplay between the immune and central nervous systems in neurological and neuropsychiatric illness, there is renewed interest in the potential contribution of immune dysregulation to the development and progression of schizophrenia. To inform this line of inquiry requires a more nuanced understanding of specific immune changes throughout the course of illness. Here, we utilized a genome-wide sequencing approach to transcriptionally profile circulating monocytes in participants with chronic schizophrenia. These myeloid cells, isolated from whole blood samples, are highly plastic with potentially important disease-modifying functions. Differential gene expression and gene set enrichment analyses, focusing on established monocyte phenotypic signatures, including those related to proinflammatory (“M1-like”) and protective or tissue remodeling (“M2-like”) functions, were carried out. We demonstrate an overall enrichment of both “M1-like” (interferon-alpha, interferon-gamma, lipopolysaccharide acute) and “M2-like” (endotoxin tolerance, glucocorticoid acute) monocyte signatures in the participants with schizophrenia compared to non-psychiatric controls. There was no enrichment of the “M1-like” chronic stress signature or the “M2-like” interleukin-4 signature. Using the Molecular Signatures Database Hallmark gene sets list, the “interferon response” was most strongly enriched in schizophrenia compared to controls. Additionally, an exploratory subgroup analysis based on illness duration suggests a shift in monocyte phenotype with illness progression. Specifically, the “M1-like” interferon-gamma signature shows decreased enrichment accompanied by increased enrichment of opposing “M2-like” signatures in participants with a medium illness duration shifting to a strong enrichment of interferon response signatures only in participants with a long illness duration. These findings related to circulating immune cell phenotype have potentially important implications for understanding the role of immune dysregulation in schizophrenia and are a critical consideration for future study design and immune-targeting treatment strategies.

Transcriptional level of inflammation markers associates with short-term brain structural changes in first-episode schizophrenia

“…Microglial cells and chemokines might recruit monocytes circulating in the peripheral blood into the brain [ 38 ], where neuroinflammation was exacerbated by these monocytes. The investigation of monocyte transcriptome demonstrated a shift in monocyte phenotype in different stages of schizophrenia [ 39 ]. In the current study, the transcriptional profile of monocyte was directly related to the longitudinal change of cortical thickness in patients, suggesting an association of monocyte gene expression with the effect of treatment and this disease itself on the brain.…”

Six Decades of Dopamine Hypothesis: Is Aryl Hydrocarbon Receptor the New D2?

“…The correlation between monocytosis and anosognosia is not new or limited to COVID-19, as it was reported earlier in the context of HIV-associated neurocognitive disorder (HAND), a condition marked by impaired insight [124]. This is significant as monocyte levels are elevated in SCZ, highlighting a potential general marker of anosognosia in neuropathology [125][126][127]. For example, a recent study found that patients in the preclinical phase of SCZ exhibited monocytosis and increased microbial translocation markers, further linking gut microbes with this pathology [128].…”

Gene expression study in monocytes: evidence of inflammatory dysregulation in early-onset obsessive-compulsive disorder

“…Although no previous work has assessed gene expression profiles in monocytes from patients with OCD, some authors have described functional dysregulation of these immune cells in other psychiatric disorders based on gene expression changes. Thus, monocytes from patients with schizophrenia, bipolar disorder, or major depressive disorder showed abnormal gene expression patterns, with alterations in processes related to immune response, proinflammatory cytokine production, and cell adhesion/migration [ 38 – 41 ]. In addition, genome-wide expression studies using whole blood from those patients found impaired gene expression in some genes mostly related to monocytes and other cells of myeloid lineage [ 42 , 43 ].…”